Memphis Tennessee Support Group Meeting

Baptist Memphis Hospital
Memphis, Tennessee
Saturday, August 23, 2014
8:30 am - 3 pm

Speakers: Dr. Jeffrey Zonder
Karmanos Cancer Institute, Detroit MI
Tara Nickerson, PhD, Chief Business Officer, and
Theresa Neumann, both from Prothena Corporation
For those of you that don't know, Prothena is the company running the NEOD001 trial
NEOD001 is a humanized monoclonal antibody designed to neutralize and clear soluble and insoluble amyloid aggregates in patients with AL Amyloidosis. Simply put, the hopes are that the drug will remove existing amyloid deposits from the body!
Complimentary breakfast and lunch will be served. Please RSVP to me at ■■■■■■■■■■■■■■■■■■■■■.

For more information and directions to Baptist Hospital go to:
Several new clinical trials are open around the country
for AL, ATTR and WT-TTR types!
See our website for more details